The sensitivity of nuclear magnetic resonance (NMR) probes, especially the recently introduced cryogenic probes, can be substantially reduced by the electrical noise generated by conductive samples. In particular, samples of biological macromolecules, which usually contain salts to keep the pH constant and to prevent aggregation, can experience a significant reduction in sensitivity. So far this dependence has forced researchers to minimize the salt concentrations in their samples. Here we demonstrate that the decisive factor is not the salt concentration itself but the conductivity which is a function of both the concentration and the mobility of the ions in solution. We show that by choosing buffers with low ionic mobility, the sample conductivity can be dramatically reduced and the sensitivity substantially enhanced compared to the same measurement with an equal concentration of a standard NMR buffer such as phosphate. We further show that the highest sensitivity gain of one buffer over another buffer is equal to the square root of the ratio of their ion mobilities and describe a simple method to evaluate the effect of a certain buffer on the sensitivity.

Cryogenic cooling of the NMR radio frequency coils and electronics to give greatly enhanced sensitivity is arguably the most significant recent advance in NMR spectroscopy. Here we report the first cryogenic probe built in flow configuration and demonstrate the application to LC-NMR-MS studies. This probe provides superior sensitivity over conventional noncryogenic flow NMR probes, allowing the use of 100 microL of untreated urine (40% less material than previous studies that required preconcentration) and yet revealing drug metabolites hitherto undetected by LC-NMR-MS at 500 MHz. Besides the known sulfate and glucuronide metabolites, previously undetected metabolites of acetaminophen were directly observable in a 15-min on-flow experiment. Simultaneous MS data also provided knowledge on the NMR-silent functional moieties. Further, stop-flow LC-NMR-MS experiments were conducted for greater signal-to-noise ratios on minor metabolites. The cryoflow probe enables the NMR analysis of lower concentrations of metabolites than was previously possible for untreated biofluids. This strategy is generally applicable for samples containing mass-limited analytes, such as those from drug metabolism studies, biomarker and toxicity profiling, impurity analysis, and natural product analysis.

No abstract

No abstract